480-907-7690 info@qfrsolutions.com
Valeant Names Howard Schiller as Interim CEO

Valeant Names Howard Schiller as Interim CEO

Source: USA Today Valeant Pharmaceuticals International, the Canadian drugmaker whose CEO has been on medical leave while it faces congressional scrutiny over its pricing practices, said Wednesday it appointed Howard B. Schiller as interim CEO, effective immediately....